altretamine has been researched along with prednimustine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Cornbleet, MA; Fletcher, S; Kerr, GR; Leonard, RC; Livingstone, JR; Smart, GE; Smyth, JF; Webb, JN | 1 |
| Balducci, L; Khansur, T; Thigpen, JT; Vance, RB | 1 |
1 review(s) available for altretamine and prednimustine
| Article | Year |
|---|---|
New drugs and experimental approaches in ovarian cancer treatment.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Aziridines; Benzoquinones; Busulfan; Carboplatin; Cisplatin; Estrogen Antagonists; Female; Galactitol; Humans; Ifosfamide; Mitomycins; Organoplatinum Compounds; Ovarian Neoplasms; Prednimustine; Progestins | 1984 |
1 trial(s) available for altretamine and prednimustine
| Article | Year |
|---|---|
Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Laparotomy; Middle Aged; Ovarian Neoplasms; Prednimustine; Prognosis; Random Allocation | 1989 |
1 other study(ies) available for altretamine and prednimustine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |